Related Experiment Video
Updated: Aug 5, 2026
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Facility Type Predicts Treatment Regimen for Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
Monica S Trent1, Kelsey Roman2, Timothy I Hsu2
1Department of Otolaryngology-Head and Neck Surgery University of California, Irvine Medical Center Orange California USA.
Objectives:
Treatment landscapes are changing for HPV+ oropharyngeal cancer (OPC) without compromising oncologic outcomes. We aim to analyze treatment trends of HPV+ OPC at academic (ACs) and nonacademic centers (NACs).
Methods:
The National Cancer Database was queried, and multinomial logistic regression was used to predict treatment trends.
Results:
In total, 30,243 HPV+ OPC patients were included; 15,155 (50.1%) at NAC and 15,088 (49.9%) at AC. More patients underwent surgery at AC (p < 0.05), were less likely to receive primary RT in ES and AS (OR = 0.57; OR = 0.80), and less likely to receive definitive CRT compared to surgery (OR = 0.62; OR = 0.76). ES patients who received surgery versus RT or CRT alone had higher 5-year overall survival (p = 0.04).
Conclusions:
ACs are more likely to utilize surgery as the primary treatment modality for HPV+ OPC rather than definitive RT or CRT. This points to a lack of standardized treatment regimens dependent on facility resources.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase